Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)

This study has been completed.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Ian Carroll, PhD, University of North Carolina, Chapel Hill Identifier:
First received: February 18, 2010
Last updated: March 10, 2016
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)